Alpha Teknova (TKNO) Competitors $4.52 -0.01 (-0.22%) Closing price 04:00 PM EasternExtended Trading$4.52 0.00 (0.00%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TKNO vs. CRMD, TSHA, IMNM, AMLX, IOVA, PHAT, URGN, TRVI, DNTH, and AVBPShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include CorMedix (CRMD), Taysha Gene Therapies (TSHA), Immunome (IMNM), Amylyx Pharmaceuticals (AMLX), Iovance Biotherapeutics (IOVA), Phathom Pharmaceuticals (PHAT), Urogen Pharma (URGN), Trevi Therapeutics (TRVI), Dianthus Therapeutics (DNTH), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Its Competitors CorMedix Taysha Gene Therapies Immunome Amylyx Pharmaceuticals Iovance Biotherapeutics Phathom Pharmaceuticals Urogen Pharma Trevi Therapeutics Dianthus Therapeutics ArriVent BioPharma CorMedix (NASDAQ:CRMD) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk. Which has stronger earnings and valuation, CRMD or TKNO? CorMedix has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorMedix$43.47M19.90-$17.93M$0.7515.45Alpha Teknova$37.74M6.41-$26.75M-$0.42-10.76 Which has more risk & volatility, CRMD or TKNO? CorMedix has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Do insiders & institutionals believe in CRMD or TKNO? 34.2% of CorMedix shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 5.3% of CorMedix shares are owned by company insiders. Comparatively, 12.5% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor CRMD or TKNO? In the previous week, CorMedix had 19 more articles in the media than Alpha Teknova. MarketBeat recorded 20 mentions for CorMedix and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.91 beat CorMedix's score of 0.48 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Overall Sentiment CorMedix Neutral Alpha Teknova Very Positive Is CRMD or TKNO more profitable? CorMedix has a net margin of 42.11% compared to Alpha Teknova's net margin of -55.24%. CorMedix's return on equity of 42.73% beat Alpha Teknova's return on equity.Company Net Margins Return on Equity Return on Assets CorMedix42.11% 42.73% 34.19% Alpha Teknova -55.24%-26.51%-18.40% Do analysts rate CRMD or TKNO? CorMedix currently has a consensus target price of $18.00, indicating a potential upside of 55.31%. Alpha Teknova has a consensus target price of $10.00, indicating a potential upside of 121.24%. Given Alpha Teknova's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Teknova is more favorable than CorMedix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorMedix 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryCorMedix beats Alpha Teknova on 12 of the 16 factors compared between the two stocks. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$241.87M$3.08B$5.69B$10.27BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-10.7621.3075.8626.51Price / Sales6.41379.80489.92165.32Price / CashN/A44.4425.8129.89Price / Book2.929.6112.846.32Net Income-$26.75M-$53.28M$3.28B$270.51M7 Day Performance6.35%0.30%0.20%2.15%1 Month Performance-3.62%4.57%4.59%6.35%1 Year Performance2.73%9.23%68.31%25.48% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova2.8111 of 5 stars$4.52-0.2%$10.00+121.2%+3.0%$241.87M$37.74M-10.76240CRMDCorMedix3.9067 of 5 stars$12.75+2.8%$17.33+35.9%+82.0%$925.65M$43.47M17.0030Analyst UpgradeTSHATaysha Gene Therapies2.452 of 5 stars$3.24-3.6%$8.29+155.7%+31.9%$916.59M$8.33M-9.53180Positive NewsIMNMImmunome2.3597 of 5 stars$9.40-10.6%$22.89+143.5%-40.6%$915.71M$9.04M-3.0540Positive NewsAMLXAmylyx Pharmaceuticals2.8136 of 5 stars$10.44+2.4%$12.25+17.3%+352.3%$909.51M$87.37M-4.18200Analyst ForecastIOVAIovance Biotherapeutics4.328 of 5 stars$2.38-4.4%$11.90+400.0%-78.0%$901.02M$164.07M-1.93500PHATPhathom Pharmaceuticals2.3724 of 5 stars$12.43+0.7%$17.50+40.8%-37.3%$875.45M$55.25M-2.63110News CoveragePositive NewsURGNUrogen Pharma4.061 of 5 stars$21.42+13.5%$32.00+49.4%+37.7%$873.47M$90.40M-6.45200Analyst UpgradeHigh Trading VolumeTRVITrevi Therapeutics2.8316 of 5 stars$7.60+8.4%$21.75+186.2%+139.2%$853.66MN/A-18.0920Positive NewsHigh Trading VolumeDNTHDianthus Therapeutics2.8813 of 5 stars$31.80+20.0%$54.00+69.8%+27.9%$852.99M$6.24M-9.7880High Trading VolumeAVBPArriVent BioPharma1.8054 of 5 stars$20.21+0.1%$39.14+93.7%-20.2%$819.09MN/A-5.0340Positive News Related Companies and Tools Related Companies CRMD Competitors TSHA Competitors IMNM Competitors AMLX Competitors IOVA Competitors PHAT Competitors URGN Competitors TRVI Competitors DNTH Competitors AVBP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TKNO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TKNO Stock Alerts